Skip to main content
logo
Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
1.110
-0.150 (-11.90%)
At close: Nov 5, 2026, 4:00 PM EST
1.144
+0.034 (3.05%)
After-hours: Nov 5, 2026, 7:30 PM EST

Anavex Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
1037644825378041,359
Market Cap Growth
-84.52%58.72%-10.27%-33.27%-40.83%396.34%
Enterprise Value
-156633433826511,202
Last Close Price
1.118.905.686.5510.3217.95

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-10.73----
PB Ratio
0.928.064.013.785.659.01
P/TBV Ratio
0.928.064.013.785.659.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Debt / Equity Ratio
-1.05-1.08-1.10-1.06-1.05-1.01
Quick Ratio
15.5111.568.8012.2714.9214.93
Current Ratio
15.6211.618.8612.3214.9514.97
Return on Equity (ROE)
-12.80%-43.11%-32.81%-33.41%-32.71%-42.58%
Return on Assets (ROA)
-9.70%-26.51%-21.81%-21.59%-18.95%-23.87%
Return on Capital Employed (ROCE)
-15.40%-53.50%-42.10%-37.40%-33.40%-24.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-13.03%-6.07%-8.93%-8.85%-5.96%-2.79%
Buyback Yield / Dilution
-5.94%-2.18%-4.61%-3.74%-10.18%-19.95%
SEC Filings: 10-K · 10-Q